![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Tuesday, April 19, 2011 10:46:55 PM
About Us
We are a biotechnology company with focus on tissue and muscle injury. Injuries to muscle such as back pain or ligaments and vascular injuries such as sclerosis are often permanent and carry significant socioeconomic consequences. About 10 million people in the United States suffer from back muscle injuries that have become a chronic back pain. Another 2-3 million suffer from sport related injuries, ligaments stretched, spasm etc. These conditions carries a life time pain, that can not be resolved by normal and usual pain killers. Pain and suffering from these injuries are due to the constant release of chemical mediators, known as cytokines. We have discovered molecules, known as growth factors that prevent the effect of these cytokines and associated pain by preventing further damage to the tissue and rebuilding the damaged tissues.
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM
ECGI Holdings Enhances Board with Artificial Intelligence (AI) Expert Ahead of Allon Apparel Launch • ECGI • Jul 10, 2024 8:30 AM
Avant Technologies to Meet Unmet Needs in AI Industry While Addressing Sustainability Concerns • AVAI • Jul 10, 2024 8:00 AM
Panther Minerals Inc. Launches Investor Connect AI Chatbot for Enhanced Investor Engagement and Lead Generation • PURR • Jul 9, 2024 9:00 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM